COMMUNIQUÉS West-GlobeNewswire

Strongbridge Biopharma plc Announces Presentation of New Data Demonstrating That Levoketoconazole is a Potent Inhibitor of Human Enzymes Controlling Cortisol Synthesis
18/03/2018
~ Data Suggest Levoketoconazole, the Isolated 2S,4R Enantiomer of Ketoconazole, Accounts for Essentially All of the Inhibition by Ketoconazole of Cortisol Biosynthesis in Humans ~ ~ Results Presented at ENDO 2018, the [...]
Radius Health Presents Positive Data for the ACTIVExtend BMD Responder Analysis for TYMLOS™ (abaloparatide) Injection at ENDO 2018 Annual Meeting
17/03/2018
WALTHAM, Mass., March 17, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS ), a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative [...]
Abeona Therapeutics Reports Fourth Quarter 2017 Financial Results and Business Highlights
16/03/2018
NEW YORK and CLEVELAND, March 16, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ: ABEO ), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life- [...]
Matinas BioPharma Appoints Jerome D. Jabbour as Chief Executive Officer and Provides Corporate Update
16/03/2018
Leadership appointment positions Company for next stage of value creation Successful outcome of meeting with FDA provided important insight and clarity for clinical development path forward for MAT2203 Conference call [...]
DBV Technologies Announces Filing of 2017 "Document de Référence" and 2017 Annual Report on Form 20-F
16/03/2018
Montrouge, France, March 16, 2018 DBV Technologies Announces Filing of 2017 "Document de Référence" and 2017 Annual Report on Form 20-F DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) [...]
DBV Technologies Publie son Document de Référence 2017 et son «Form 20-F» américain
16/03/2018
Montrouge, France, le 16 mars, 2018 (21:30 CET) DBV Technologies Publie son Document de Référence 2017 et son «Form 20-F» américain DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq : DBVT), une société [...]
Reata Selected to Present Early-Stage Programs at the BIO Asia International Conference
16/03/2018
IRVING, Texas, March 16, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA ) (Reata or Company), a clinical-stage biopharmaceutical company, today announced that Chief Development Officer, Keith Ward, [...]
Geron Corporation Reports Fourth Quarter and Annual 2017 Financial Results and Recent Events
16/03/2018
MENLO PARK, Calif., March 16, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN ) today reported financial results for the fourth quarter and year ended December 31, 2017 and recent events. Fourth Quarter and [...]
NEXSTIM PLC ENDS NEGOTIATIONS WITH POTENTIAL CHINESE PARTNER
16/03/2018
Company announcement, Helsinki, 16 March 2018 at 18:30 PM NEXSTIM PLC ENDS NEGOTIATIONS WITH POTENTIAL CHINESE PARTNER Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company"), the targeted neuromodulation company [...]
Canada House Wellness Group Announces Six-Month Extension to the Term of Warrants Issued on March 13, 2015
16/03/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, March 16, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“ Canada House ” or the “ Company ”) announces [...]
Progressive Care to Present at The Wall Street Investor Forum 26th Annual Investor Conference
16/03/2018
MIAMI, March 16, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announced today that it will be presenting at The Wall Street Investor Forum 26 th Annual [...]
Kane Biotech Schedules Fourth Quarter and Full Year 2017 Earnings Conference Call and Business Update
16/03/2018
WINNIPEG, Manitoba, March 16, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: KNE ) (OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) is pleased to announce that it will host a conference call on Thursday, March [...]
ProPhase Labs to Release Fiscal 2017 Results on Wednesday, March 21st
16/03/2018
DOYLESTOWN, Pa., March 16, 2018 (GLOBE NEWSWIRE) -- ProPhase Labs (NASDAQ: PRPH ) announced today that financial results for the year ended December 31, 2017, will be released before the market opens on Wednesday, March [...]
Hydropothecary partners with Segra to scale-up production in preparation for cannabis legalization
16/03/2018
GATINEAU, Quebec, March 16, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation (TSXV:THCX) (“Hydropothecary” or the “Company”) is pleased to announce its agreement with Segra International Corp. (“Segra”) to [...]
Hydropothecary s’associe à Segra pour intensifier la production en vue de la légalisation du cannabis
16/03/2018
GATINEAU, Québec, 16 mars 2018 (GLOBE NEWSWIRE) -- La société Hydropothecary (TSX CROISSANCE:THCX) (« Hydropothecary » ou la « Société ») a le plaisir d’annoncer la conclusion d’une entente avec Segra International Corp [...]
Delcath Announces 2017 Financial Results
16/03/2018
NEW YORK, March 16, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, announces financial results for the [...]
Tabula Rasa HealthCare to Exhibit and Present at APhA Annual Meeting and Exposition
16/03/2018
MOORESTOWN, N.J., March 16, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc . (“TRHC”) (NASDAQ: TRHC ) a healthcare technology company optimizing medication safety by deploying new medication risk identification [...]
Bavarian Nordic Announces Partnership with U.S. Department of Defense to Combat Equine Encephalitis Virus
16/03/2018
Collaboration valued up to $36M Multivalent vaccine designed to protect humans against Eastern, Venezuelan, and Western equine encephalitis virus COPENHAGEN, Denmark, March 16, 2018 - Bavarian Nordic A/S (OMX: BAVA, OTC [...]
Zosano Reaches Enrollment Milestone in M207-ADAM Long-term Safety Study
16/03/2018
FREMONT, Calif., March 16, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corp. (NASDAQ: ZSAN ) (“Zosano” or the “Company”) a clinical stage biopharmaceutical company focused on providing rapid systemic administration of [...]

Pages